Targeting Myeloid Epithelial Tyrosine Kinase (MERTK) Receptor in Acute Myeloid Leukemia Using a Novel Antibody Drug Conjugate, Rgx-019-MMAE

被引:1
|
作者
Tyagi, Anudishi [1 ]
Siddiqui, Maryam
Kurth, Isabel [2 ]
Takeda, Shugaku [2 ]
Eckstrom, Amanda [1 ]
Borgman, Jenny [1 ]
Maiti, Abhishek [3 ]
Battula, Venkata Lokesh [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA
[2] Inspirna Inc, New York, NY USA
[3] MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA
关键词
D O I
10.1182/blood-2023-175048
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Targeting myeloid epithelial tyrosine kinase (MERTK) receptor in acute myeloid leukemia using a novel antibody-drug conjugate, RGX-019-MMAE
    Tyagi, Anudishi
    Siddiqui, Maryam
    Kurth, Isabel
    Takeda, Shugaku
    Eckstrom, Amanda
    Borgman, Jenny
    Maiti, Abhishek
    Battula, Venkata Lokesh
    CANCER RESEARCH, 2024, 84 (06)
  • [2] RGX-019-MMAE, a novel MERTK-targeting antibody-drug conjugate (ADC) with robust anti-tumor efficacy in both solid and liquid tumors.
    Takeda, Shugaku
    Lo, PuiChi
    Schefer, Daniel
    Andreu-Agullo, Celia
    Battula, Venkata Lokesh
    Maiti, Abhishek
    Tavazoie, Masoud
    Darst, David Martin
    Kurth, Isabel
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] Targeting receptor tyrosine kinase signaling in acute myeloid leukemia
    Doepfner, Kathrin T.
    Boller, Danielle
    Arcaro, Alexandre
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 63 (03) : 215 - 230
  • [4] MER RECEPTOR TYROSINE KINASE AS A POTENTIAL NOVEL TARGET IN ACUTE MYELOID LEUKEMIA
    Eisenman, Kristen
    Sather, Susan
    McGranahan, Amy
    Liang, Xiayaun
    Desch, Ashley
    Cannon, Cara
    Martinson, Hollie
    Keating, Amy
    Graham, Doug
    PEDIATRIC BLOOD & CANCER, 2010, 54 (06) : 790 - 790
  • [5] Immunotherapeutic Targeting of Mesothelin in Acute Myeloid Leukemia in Vitro with Anetumab Ravtansine and a Novel Antibody-Drug Conjugate
    Kaeding, Allison
    Tarlock, Katherine
    Kolb, E. Anders
    Meshinchi, Soheil
    BLOOD, 2018, 132
  • [6] Combinatorial Targeting of the c-KIT Receptor Tyrosine Kinase in Acute Myeloid Leukemia
    Murray, Heather
    Enjeti, Anoop K.
    Kahl, Richard
    Flanagan, Hayley
    Verrills, Nikki
    Dun, Matthew
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 14 - 14
  • [7] MerTK Receptor Tyrosine Kinase Inhibition As a Potential Strategy to Augment Immune-Mediated Clearance of Acute Myeloid Leukemia
    Page, Lauren Shelby
    Wang, Xiaodong
    Earp, H. Shelton, III
    Frye, Stephen
    Jordan, Craig T.
    Lee-Sherick, Alisa B.
    BLOOD, 2016, 128 (22)
  • [8] Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia
    Kentsis, Alex
    Reed, Casie
    Rice, Kim L.
    Sanda, Takaomi
    Rodig, Scott J.
    Tholouli, Eleni
    Christie, Amanda
    Valk, Peter J. M.
    Delwel, Ruud
    Vu Ngo
    Kutok, Jeffery L.
    Dahlberg, Suzanne E.
    Moreau, Lisa A.
    Byers, Richard J.
    Christensen, James G.
    Woude, George Vande
    Licht, Jonathan D.
    Kung, Andrew L.
    Staudt, Louis M.
    Look, A. Thomas
    NATURE MEDICINE, 2012, 18 (07) : 1118 - +
  • [9] Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia
    Alex Kentsis
    Casie Reed
    Kim L Rice
    Takaomi Sanda
    Scott J Rodig
    Eleni Tholouli
    Amanda Christie
    Peter J M Valk
    Ruud Delwel
    Vu Ngo
    Jeffery L Kutok
    Suzanne E Dahlberg
    Lisa A Moreau
    Richard J Byers
    James G Christensen
    George Vande Woude
    Jonathan D Licht
    Andrew L Kung
    Louis M Staudt
    A Thomas Look
    Nature Medicine, 2012, 18 : 1118 - 1122
  • [10] Targeting the FMS-like tyrosine kinase 3 in acute myeloid leukemia
    R Swords
    C Freeman
    F Giles
    Leukemia, 2012, 26 : 2176 - 2185